Assessment of acrylic bone cement as a local delivery vehicle for the application of non-steroidal anti-inflammatory drugs

Biomaterials

Volumn 19, Issue 14, 1998, Pages 1295-1301

  Corry, D ^a   Moran, J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Local delivery vehicle; NSAID; Periodontitis; PGE2

Indexed keywords

COMPOSITION EFFECTS; CONTROLLED DRUG DELIVERY; DRUG DOSAGE; DRUG PRODUCTS; LIGAMENTS; POLYMETHYL METHACRYLATES;

ACRYLIC BONE CEMENT; ANTI INFLAMMATORY DRUGS; PERIODONTITIS;

BONE CEMENT;

ACRYLIC CEMENT; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INDOMETACIN; MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; TOLMETIN;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; FIBROBLAST; GASTROINTESTINAL HEMORRHAGE; HUMAN; HUMAN CELL; PERIODONTICS; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE CEMENTS; CELLS, CULTURED; DELAYED-ACTION PREPARATIONS; DINOPROSTONE; DRUG CARRIERS; FIBROBLASTS; HUMANS; INDOMETHACIN; MEFENAMIC ACID; PERIODONTAL LIGAMENT; PERIODONTITIS; POLYMETHYL METHACRYLATE; TOLMETIN;

ESCHERICHIA COLI;

EID: 0032125817     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(98)00012-X     Document Type: Article

References (26)

1. 2 levels and human periodontal disease. Prostaglandins 1974;6:81-5.
2. [2] Masada MP, Persson R, Kenny JS, Lee SW, Page RC, Allison AC. Measurement of interleukin 1-α and 1-β in gingival cervicular fluid: implications for the pathogenesis of periodontal disease. J Periodontal Res 1990;25:156-63.
3. 2 in cervicular fluid. J Clin Periodontol 1981;8:319-27.
4. [4] Offenbacher S, Odle BM, Van Dyke TE. The use of crevicular fluid prostaglandin E2 levels as predictors of attachment loss. J Periodontal Res 1986;21:101-12.
5. [5] Offenbacher S, Odle BM, Braswell D et al. Changes in cyclooxygenase metabolites in experimental periodontitis in Macca mulatta. J Periodontal Res 1989;24:63-74.
6. 2 release from human monocytes. J Periodontol 1988; 59:684-57.
7. [7] Richards D, Rutherford RB. The effects of interleukin-1α on collagenolytic activity and prostaglandin E secretion by human peridontal ligament and gingival fibroblasts. Arch Oral Biol 1988;33:237-43.
8. [8] Klein DC, Raisz LG. Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology 1970;86:1436-40.
9. [9] Williams TJ, Peck MJ. Role of prostaglandin mediated vasodilation in inflammation. Nature 1977;270:530-2.
10. 2 regulates mononuclear cell immunoglobulin production. J Periodontol 1995;66:222-7.
11. [11] Arai H et al. Response of human gingival fibroblasts to prostaglandins. J Periodontal Res 1995;30:303-11.
12. 2, immunoreactive leukotrine and pain after periodontal surgery. J Periodontol 1996; 67:1307-16.
13. [13] Vogel RI, Schneider L, Goteiner D. The effects of a topically active non-steroidal anti-inflammatory drug on ligature induced periodontal disease in the squirrel monkey. J Clin Periodontol 1986;13:139-44.
14. [14] Williams RC, Jeffcoat MK, Howell TH et al. Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol 1989;60:485-90.
15. [15] Waite IM, Saxton CA, Young A, Wagg BJ, Corbett M. The periodontal status of subjects recieving non-streoidal anti-inflammatory drugs. J Periodontal Res 1981;16:100-8.
16. [16] Carson JL, Strom BL, Morse ML et al. The relative gastrointestinal toxicity of the non-steroidal anti-inflammatory drugs. Arch Intern Med 1987;147:1054-9.
17. [17] ABPI Data Sheet Compendium, 1995-1996. Datapharm Publishing Ltd., 1995.
18. [18] Addy M, Rawle R, Handley R, Newman HN, Coventry JF. The development and in vitro evaluation of acrylic strips and dialysis tubing for local drug delivery. J Periodontol 1982;53:693-9.
19. [19] Addy M, Hassan H, Moran J, Wade W, Newcombe R. Use of antimicrobial containing strips in the treatment of chronic periodontal disease. J Periodontol 1988;59:557-64.
20. [20] Abu Fanas S, Drucker D, Hull P. Evaluation of acrylic strips containing amoxycillin with clavulanic acid for local drug delivery. J Dent 1991;19:92-6.
21. [21] Fries JF, Williams CA, Bloch DA. The relative toxicity of non-steriodal anti-inflammatory drugs. Arthritis Rheum 1991;34: 1353-60.
22. [22] Alsharabi A, Moran J. Antimicrobial activity of non-steriodal anti-inflammatory drugs in acrylic. Abstract. J Dent Res 1995;74:1381.
23. [23] Hirji M, Greenman J, Moran J. Antimicrobial activity of selected non-steroidal anti-inflammatory drugs. Abstract. J Dent Res 1996;75:461.
24. [24] Heasman PA, Offenbacher S, Collins SG, Edwards G, Seymour R. Flurbiprofen in the prevention and treatment of experimental gingivitis. J Clin Periodontol 1993;20:732-8.
25. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-44.
26. [26] Moran J, Addy M, Wade W, Newcombe R. The use of antimicrobial acrylic strips in the non-surgical management of chronic periodontitis. Clin Mater 1990;6:123-35.